pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
JOURNEY · news · pharmadog
← back to JOURNEY
News mentioning JOURNEY
113
stories
Jul 23, 26
STAT+: Pharmalittle: We’re reading about Lilly obesity drug data, a push for FDA to ban DTC ads, and more
stat
Jul 22, 26
From Big Pharma to specialty: why moving closer to the patient changes everything
biospace
Jul 20, 26
‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong Kong
fiercebiotech
Jul 20, 26
Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independence
biospace
Jun 30, 26
STAT+: All of Us tests a new approach to collect real-world data for research
stat
Jun 25, 26
De-Risking a Rare Disease Launch Starts with Precision
fiercebiotech
Jun 16, 26
FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
biopharma dive
Jun 10, 26
Opinion: ‘They all think I’m insane’: What it’s like to start medical residency at 72
stat
Jun 4, 26
Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise
stat
Jun 3, 26
STAT+: What the pope’s encyclical on AI means for Catholic hospitals, and all of health care
stat
May 29, 26
Replimune takes third swing at cancer drug approval following ‘productive’ FDA talks
biopharma dive
May 18, 26
STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more
stat
May 12, 26
PCOS’s new name is PMOS, a small letter change that required a big scientific process
stat
May 11, 26
STAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and more
stat
May 11, 26
Precision in motion: Decoding the critical operations behind the logistics of next-generation cell and gene therapies
biopharma dive
May 8, 26
Opinion: We need more men in nursing
stat
May 7, 26
Key takeaways from WHO briefing on hantavirus cruise ship outbreak
stat
May 7, 26
Angelini to buy Catalyst in $4B play for rare neuro drugs
biopharma dive
May 5, 26
Coordinating Care in Multiple Myeloma Across Practice Settings
onclive
Apr 29, 26
Food safety experts warn of USDA brain drain
stat
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
Apr 27, 26
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder
biopharma dive
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
← prev
page 4 of 4
next →
